Assessment of the new safety reporting portal (SRP) reporting form
Ended Awarded Last action
- Contract number
- 75F40121F19006
- Awardee
-
Westat, Inc. UEI NVUWAFWQ57S5
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $307,258
Award facts
- Contract value 100% obligated
- $307,258.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541820 Public Relations Agencies
- PSC
- B599 Special Studies/Analysis- Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $185,428 | |
| Other Administrative Action | $0 | |
| Original award | $121,830 |
About this award
The Food and Drug Administration (FDA) awarded a $307,258 firm fixed-price contract to Westat, Inc. on June 29, 2021, under a Blanket Purchase Agreement (BPA) call with an ultimate completion date of September 30, 2026. The contract is issued under the General Services Administration's Advertising & Integrated Marketing Solutions (AIMS) master schedule and calls for an assessment of the FDA's new Safety Reporting Portal (SRP) reporting form. This engagement supports the FDA's efforts to evaluate and optimize its adverse event and safety reporting systems, which are critical to the agency's mission of protecting public health through the monitoring of product safety.
Westat, Inc., a large, established research and professional services firm headquartered in Rockville, Maryland, brings substantial expertise to this engagement. The company specializes in research, data collection, analysis, and program evaluation services and maintains an extensive portfolio of federal contracts with agencies including the FDA, Centers for Disease Control and Prevention, and National Institutes of Health. No small business set-aside designation was applied to this award, reflecting Westat's competitive standing as a prime contractor capable of executing complex technical assessments. The contract received no competitive set-aside restrictions and represents a call against Westat's existing AIMS agreement with GSA.
Quick answers
Who was awarded contract 75F40121F19006?
75F40121F19006 was awarded to Westat, Inc. by Food and Drug Administration (Department of Health and Human Services) on June 29, 2021.
How much is contract 75F40121F19006 worth?
The government has obligated $307,258 on 75F40121F19006.
Is contract 75F40121F19006 an order under another contract?
Yes. 75F40121F19006 is a BPA call under GS23F0155K-75F40120A00018, a blanket purchase agreement, on Advertising & Integrated Marketing Solutions (AIMS).
Was contract 75F40121F19006 competed?
The extent of competition for 75F40121F19006 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award